Prostate Cancer: The Silent Disease Every Man Should Understand
The cancer that often gives no warning

Imagine feeling perfectly healthy, going about your daily routine, and discovering through a simple blood test that you have cancer.
No pain. No warning signs. Nothing that would have made you think something was wrong.
For many men diagnosed with prostate cancer, that is exactly how their journey begins.
Prostate cancer is one of the most common cancers affecting men. According to the American Cancer Society, approximately 1 in 8 men will be diagnosed with prostate cancer during their lifetime. In 2026 alone, an estimated 333,830 American men will receive this diagnosis.
But here is the encouraging part: A prostate cancer diagnosis does not automatically mean a shortened life, and it certainly does not always mean aggressive treatment.
Today, advances in early detection, magnetic resonance imaging (MRI), robotic surgery, radiation therapy, and personalized cancer care have transformed how we diagnose and manage this disease.
As a urologic surgeon specializing in prostate cancer and robotic surgery, I believe one of the most important things we can do is help men understand their risks before a problem develops.
The goal is not simply to detect more prostate cancer. It is to identify dangerous cancers early enough to make a difference while avoiding unnecessary treatment of cancers that may never cause harm.
What is the prostate, and why does prostate cancer develop?
The prostate is a small gland, approximately the size of a walnut, located just below the bladder. Its primary job is to produce some of the fluid that makes up semen.
The prostate surrounds the urethra, the tube that carries urine from the bladder out of the body. This location helps explain why prostate problems can sometimes cause urinary symptoms.
Prostate cancer develops when cells within the prostate begin growing abnormally and uncontrollably.
Not all prostate cancers behave the same way.
Some grow so slowly that they may never threaten a man's health. Others are more aggressive and can spread beyond the prostate, including into nearby tissues, lymph nodes, and bones.
Understanding which type of cancer a patient has is one of the most important parts of determining the right treatment.
What are the early warning signs of prostate cancer?
Here's something that surprises many patients:
Early prostate cancer usually causes no symptoms.
A man can have prostate cancer while urinating normally, experiencing no pain, and feeling completely healthy.
When symptoms do occur, they may include:
Difficulty starting urination or a weak urine stream
Frequent urination, particularly at night
Blood in the urine or semen
Discomfort with urination or ejaculation
Persistent bone pain, particularly with more advanced disease
Unexplained weight loss or fatigue in advanced cases
However, these symptoms do not necessarily mean cancer.
Many urinary problems are caused by benign prostatic hyperplasia (BPH), commonly called an enlarged prostate, or by infections and other noncancerous conditions.
In fact, prostate enlargement becomes increasingly common as men age.
The important message is that waiting until symptoms develop is not a reliable strategy for detecting prostate cancer early.
Who is at risk for prostate cancer?
Although any man can develop prostate cancer, several factors can increase the risk.
Age: Prostate cancer becomes more common as men grow older, particularly after age 50.
Family history: Having a father, brother, or other close relative with prostate cancer can increase your risk, especially if the relative was diagnosed at a younger age.
Ancestry: Black men have a higher risk of developing prostate cancer and dying from the disease, making conversations about early screening particularly important.
Genetics: Inherited changes in certain genes, including BRCA1 and BRCA2, may increase prostate cancer risk. Some of these mutations are also associated with breast, ovarian, and pancreatic cancers in family members.
Having these risk factors does not mean someone will develop cancer. It means that screening decisions should be personalized rather than based on age alone.
When should men start prostate cancer screening?
This is one of the questions I hear most often, and the answer depends on individual risk.
The main screening tool is a blood test called prostate-specific antigen (PSA).
Based on recommendations from the American Urological Association and other professional organizations, the following ages provide a useful starting point:
Your risk | When to discuss PSA screening |
Average risk | Ages 45–50 |
Black ancestry, strong family history, or inherited genetic risk | Ages 40–45 |
Multiple close relatives diagnosed at young ages | As early as age 40, with individualized guidance |
These are ages to begin discussing screening, not a requirement that every man undergo testing. Guidelines differ somewhat, and screening decisions should consider life expectancy, personal values, and the benefits and potential harms of testing.
What is a PSA test?
PSA is a protein produced by prostate cells. A small amount normally circulates in the bloodstream and can be measured through a routine blood test.
Elevated PSA levels can indicate a prostate problem, but they do not automatically mean cancer.
PSA can increase because of prostate enlargement, inflammation, infection, or other factors.
Likewise, a PSA level within the laboratory's normal range does not completely exclude prostate cancer.
Rather than looking at a single number in isolation, a urologist considers the patient's age, prostate size, prior PSA results, family history, and other risk factors.
A newly elevated PSA is often repeated before additional testing because levels can fluctuate or return to normal.
Is the PSA test perfect?
No medical screening test is perfect, and PSA is no exception.
Screening may detect cancers early enough to reduce the risk of death, but it can also lead to false alarms, unnecessary biopsies, and the diagnosis of slow-growing cancers that would never have caused problems.
That's why modern prostate cancer screening emphasizes informed, shared decision-making rather than testing every man in exactly the same way.
What happens if your PSA is elevated?
An elevated PSA is not a cancer diagnosis.
It is simply a reason to investigate further.
Depending on the circumstances, a urologist may recommend repeating the PSA test, assessing other risk factors, using additional blood or urine biomarkers, or obtaining prostate imaging.
One of the most important advances in prostate cancer diagnosis has been the use of multiparametric prostate MRI.
How MRI has changed prostate cancer detection
Unlike a PSA blood test, which provides an indirect indication of potential prostate problems, an MRI allows physicians to examine the prostate and look for suspicious areas.
MRI can help determine whether a biopsy is necessary and identify which parts of the prostate deserve particular attention.
If a suspicious area is found, imaging can help guide targeted tissue sampling.
What is a prostate biopsy?
A prostate biopsy involves collecting small samples of prostate tissue that are examined under a microscope to determine whether cancer is present.
Biopsies can be performed through the rectum or through the skin between the scrotum and anus, known as the perineum.
The transperineal approach has become increasingly attractive because of its lower risk of certain infectious complications.
Biopsy results help determine not only whether cancer exists, but also how aggressive it may be.
Understanding your prostate cancer diagnosis
If prostate cancer is diagnosed, one of the first questions patients ask is:
"How serious is my cancer?"
The answer depends on several factors.
These include the PSA level, imaging findings, whether cancer has spread beyond the prostate, and the appearance of cancer cells under the microscope.
A pathology report typically includes a Gleason score and a Grade Group.
Grade Groups range from 1 through 5.
Generally, Grade Group 1 represents the least aggressive category, while Grade Group 5 represents the most aggressive.
This information helps physicians categorize prostate cancer as low, intermediate, or high risk and determine whether treatment is necessary.
Importantly, not every man diagnosed with prostate cancer needs immediate surgery, radiation, or medication.
Modern prostate cancer treatments: What are your options?
The treatment of prostate cancer has changed dramatically over the past several decades.
Today's approach is increasingly personalized, taking into account both the biology of the cancer and the individual patient's priorities.
1. Active surveillance: Sometimes the best treatment is careful monitoring
For men with certain low-risk prostate cancers, immediate treatment may provide little benefit while exposing them to unnecessary side effects.
Active surveillance involves closely monitoring the cancer with PSA tests, clinical follow-up, MRI when appropriate, and periodic prostate biopsies.
If testing suggests that the cancer is becoming more aggressive, treatment can then be considered.
Active surveillance is not ignoring cancer. It is a structured medical strategy designed to preserve quality of life without compromising the opportunity for effective treatment in appropriately selected patients.
2. Robotic prostatectomy: Removing the prostate through minimally invasive surgery
A radical prostatectomy involves removing the prostate gland and seminal vesicles, and in selected cases, nearby lymph nodes.
Modern robotic surgical systems allow surgeons to perform this procedure through small incisions using highly controlled instruments and magnified three-dimensional visualization.
Potential advantages of minimally invasive robotic surgery include smaller incisions, reduced blood loss compared with traditional open surgery, and shorter hospitalization for many patients.
However, robotic technology is a surgical tool and not a guarantee of superior cancer control or freedom from side effects.
Surgical experience, patient selection, cancer characteristics, and careful technique remain critically important.
What is single-port robotic prostate surgery?

Traditional multiport robotic surgery uses several small abdominal incisions to introduce surgical instruments.
Single-port robotic technology enables multiple instruments and a camera to pass through a single access site.
In selected patients, single-port surgery can also provide alternative approaches to the prostate, including extraperitoneal and transvesical techniques.
These approaches may reduce the need to enter the abdominal cavity or move surrounding structures during surgery.
Not everyone is a candidate for every surgical approach, and no single technique is best for all patients.
The ultimate goal is to safely remove the cancer while giving patients the best possible opportunity to preserve urinary control, sexual function, and overall quality of life.
3. Radiation therapy: Treating cancer without surgically removing the prostate
Radiation therapy uses carefully directed energy to destroy cancer cells.
Modern techniques include external beam radiation therapy, stereotactic body radiation therapy (SBRT), and brachytherapy, which places radioactive sources within the prostate.
For appropriately selected patients with localized prostate cancer, radiation offers a potentially curative alternative to surgery.
Some patients also benefit from hormone therapy given alongside radiation.
Radiation has its own potential side effects, including urinary irritation, bowel symptoms, and sexual dysfunction. These may develop during treatment or years afterward. Hormone therapy may significantly increase these risks and add additional side effects.
4. Hormone therapy: Slowing prostate cancer growth
Prostate cancer cells often depend on testosterone and related male hormones to grow.
Androgen deprivation therapy (ADT) lowers the body's production of these hormones or interferes with their effects.
Hormone therapy may be used alongside radiation for higher-risk localized disease, or as part of treatment for recurrent or metastatic cancer.
Possible side effects include fatigue, hot flashes, reduced sexual interest, loss of muscle mass, and bone thinning.
5. Advanced prostate cancer treatments
When prostate cancer has spread beyond the prostate, additional treatments may be appropriate.
These include newer hormone-blocking medications, chemotherapy, targeted therapies for certain genetic mutations, and specialized treatments that deliver radiation to cancer cells.
One example is PSMA-targeted radioligand therapy, which can be used in selected patients with advanced prostate cancer.
For some men, genetic testing or tumor testing may help identify additional treatment options.
Advances in these treatments mean that even when prostate cancer cannot be cured, it can sometimes be controlled for years while maintaining meaningful quality of life.
Can prostate cancer be cured?
Yes. Many men diagnosed with prostate cancer can be cured, particularly when the disease is confined to the prostate.
However, cure rates vary according to cancer stage, aggressiveness, overall health, and treatment.
The National Cancer Institute reports an approximately 98% five-year relative survival rate across all stages combined in recent U.S. data. That figure reflects a wide range of cancer presentations and should not be interpreted as an individual patient's prognosis.
For a newly diagnosed patient, the most important step is determining the characteristics of the specific cancer rather than assuming the diagnosis has the same meaning for everyone.
Frequently asked questions about prostate cancer
Does a high PSA mean I have prostate cancer?
No. Elevated PSA can result from prostate enlargement, inflammation, infection, or cancer. Further evaluation may be necessary to determine the cause.
Can you have prostate cancer with a normal PSA?
Yes. A normal-range PSA cannot completely rule out prostate cancer. Physicians interpret PSA results alongside individual risk factors and other clinical information.
Does an enlarged prostate lead to prostate cancer?
No. Benign prostatic hyperplasia (BPH) is not prostate cancer and does not itself turn into cancer. However, the two conditions can exist at the same time.
Does prostate cancer always require surgery?
No. Some cancers can be safely monitored, while others may be treated with radiation, surgery, or medications. The appropriate approach depends on cancer risk and patient preferences.
Is robotic prostate surgery better than traditional surgery?
Robotic surgery offers technical advantages, such as magnified visualization and precise instrument movement. However, the best outcomes depend on surgical expertise and individual patient factors. Robotic surgery does not eliminate the possibility of complications.
Will prostate cancer surgery cause urinary incontinence?
Urinary leakage can occur after radical prostatectomy. Many men experience improvement during recovery, but some have persistent symptoms that may require additional treatment.
Will I still be able to have sex after prostate cancer treatment?
Sexual function may be affected by surgery, radiation, or hormone therapy. Recovery depends on pre-treatment function, age, treatment type, nerve preservation when appropriate, and other factors.
Medications, vacuum devices, injections, and penile prostheses may help men who experience erectile dysfunction.
Can prostate cancer return after treatment?
Yes. Prostate cancer can recur after surgery or radiation, even years later. Regular follow-up with PSA testing is essential. If recurrence occurs, additional treatment may still be effective.
Can prostate cancer be prevented?
There is no guaranteed way to prevent prostate cancer.
Maintaining a healthy weight, exercising regularly, avoiding tobacco, and eating a balanced diet are reasonable ways to support overall health, although none completely eliminates prostate cancer risk.
If I feel perfectly healthy, do I still need to consider screening?
Yes. Men who are eligible for screening should discuss its benefits and risks with their healthcare provider, even when they have no urinary problems or other symptoms.
Five questions every man should ask his doctor
If you are approaching screening age—or have a family history of prostate cancer—consider asking:
Based on my age and family history, when should I begin PSA screening?
What does my PSA level mean for someone with my individual risk factors?
If my PSA is elevated, should I have additional testing or an MRI?
If prostate cancer is discovered, how aggressive is it, and does it actually require treatment?
What treatment options offer the best balance between cancer control and preserving my quality of life?
Final thoughts: Take control of your prostate health
Men often do an excellent job taking care of their families, their careers, and their responsibilities.
But when it comes to their own health, they sometimes place themselves at the bottom of the list.
Prostate cancer reminds us why that needs to change.
We cannot control every risk factor. We cannot guarantee that screening will detect every cancer. And we cannot prevent every diagnosis.
But we can become better informed, understand our individual risks, and make thoughtful decisions about our health.
Modern prostate cancer care is no longer simply about detecting cancer and removing it. It is about identifying the cancers that matter, selecting the right treatment when treatment is needed, and protecting the life patients want to live afterward.
The best time to understand your risk is not after a cancer diagnosis. It is before one.
This November, during Men's Health Awareness Month, make a commitment to understanding your prostate health and encourage the men in your life to do the same.
About the author
Dr. Jaschar Shakuri, DO is a urologic oncologic and robotic surgeon based in Morgantown, West Virginia, specializing in minimally invasive and robotic treatments for prostate cancer and other urologic conditions. His clinical interests include single-port robotic surgery, advanced prostate cancer treatment, and innovations designed to improve surgical outcomes and recovery.
Medical disclaimer: This article provides general educational information and is not a substitute for individualized medical advice, diagnosis, or treatment. Patients should discuss screening decisions and treatment options with a qualified healthcare professional.






Comments